Scientists from various countries are engaged in finding a cure for the worldwide epidemic caused by a coronavirus. The research and clinical trials on its vaccine are also showing positive results. On the other hand, the possibility of its treatment is being explored in already available medicines and medicines. Meanwhile, the good news is that a drug rich in Ayurvedic properties can be effective against Ashwagandha coronavirus infection. Research at IIT Delhi and a Japan-based institute of technology have found that ashwagandha can prove to be an effective drug to prevent treatment with Covid-19 infection.
According to the researchers, the natural compound of waxy gum found inside ashwagandha and propolis, the beehive, has the potential to become a Covid-19 inhibitor. According to D Sundar, head of the Department of Biotechnology, IIT Delhi, the scientists involved in the research team have seen great potential during the research.
According to D. Sundar, scientists targeted the main SARS-Covid-2 enzyme that plays a key role in replicating the virus. He said that the research results could save the time and cost required for testing of anti-Kovid-19 drugs. Along with this, they can prove to be important in the management of the corona epidemic.
Scientists need to conduct more clinical trials of ashwagandha and propolis in the laboratory. According to D. Sundar, it may take some time to develop medicine. Ashwagandha and propolis may prove effective in the current scenario.
The information research was conducted by Japan’s National Institute of Advanced Industrial Science and Technology (AIST) with IIT Delhi. Earlier research is being done to find the hope of prevention of corona in Ashwagandha along with other medicines in the direction of the Ministry of AYUSH.
A recent study by DAILAB at IIT Delhi and the National Institute of Advanced Industrial Science and Technology (AIST), Japan, has recently shown that ashwagandha may be an efficient Covid-19 drug. The study was carried out by Professor D Sundar, Coordinator of DAILAB at IIT Delhi and Head of the Department of Biochemical Engineering and Biotechnology at IIT Delhi.
We usually know the Ayurveda information for the ayurvedic herb Ashwagandha Covid-19 (COVID-19) can be a curative and effective drug against infection and we know that This has been found based on research at IIT Delhi (IIT-Delhi) and a Japan Institute of Technology.
As per the research team, the natural compound of ashwagandha and ‘propolis’ (waxy gum found inside the beehive) has the potential to become a coronavirus-preventing drug.
“The scientists involved in the study team targeted the main SARS-Covi-2 enzyme that played a key role in replicating the virus during the research,” said D Sundar, head of the biotechnology department of the Indian Institute of Technology (IIT), Delhi.
D Sundar said, “The results of the research can not only save the time and cost required for testing anti-Kovid-19 drugs, but they can also prove to be important in the management of coronavirus epidemics. Therefore, further laboratory tests were conducted in its laboratory needs to go.”
We get to know that The research team found that natural compounds of ashwagandha and propolis have the potential to be effective for Covid-19 drug candidates. The coronavirus started spreading in China’s Chinese city of Wuhan in December 2019, which spread like fire all over the world, and by May 17, 2020, it has infected about 45 lakh 25 thousand 497 persons worldwide and more than three lakh seven thousand people. Has died Due to this disease, the economies of the whole world have come to a standstill and the physical condition of the people, as well as the economic condition, is deteriorating.
Although some treatment options including Remedisvir, Hydroxychloroquine, Lopinavir, Ritonavir, Favilvir are under clinical trials worldwide, no effective therapy has yet been announced. However, in the current scenario of the increasing number of infected people, the severity of the disease, and the reassembly of existing drugs, a new beginning has been made for the development of medicine and vaccine worldwide.
According to Sundar, it may take some time to develop the medicine and in the current scenario, these natural resources Ashwagandha and Propolis can be of medical importance.
This research has been done by IIT Delhi with the National Institute of Advanced Industrial Science and Technology (AIST) of Japan.
Importantly, the government has also started a study on whether Ashwagandha can become an alternative to the anti-malarial drug hydroxychloroquine as a potential drug to prevent Covid-19.
Professor D. Sundar, head of the Department of Biochemical Engineering and Biotechnology at IIT Delhi and Coordinator of DAI Lab said that the traditional medical system, Ayurveda, has been prevalent in India for thousands of years. For the past decade, researchers at IIT Delhi and AIST have been studying by merging traditional knowledge with modern technologies.
Based On Drug Theory ‘Vocal’ on ‘Local’: Drug dependencies will have to be eliminated, these figures are startling
The new study revealed that Vithonone, a chemical compound in Ashwagandha, has the ability to block the ongoing replication of the coronavirus in the body. The professor said that along with this, we have also detected a chemical compound caffeic acid phone thy easter (CAPE) inside the beehive that can inhibit the activity of Sorce COV-2M Pro in the human body.
Corona Test Kit ‘feluda’ Created By Delhi Scientists, Will Give Results In A Very Short Time
Sundar said that in this research, researchers have done this study by targeting the main enzyme man protease of SORS-COV-2, which divides proteins in the body. It plays an important role in replication in the body of the virus. Both the compounds we have found have the potential to eliminate the main enzyme man protease of SORS-COV-2, responsible for the replication of viruses in the human body.
This formula has been invented by the joint team of IIT-AIST. This may lead to an effective drug against corona in the future. D Sundar said, “There is churn on how we will work on this further. Our effort is in the initial phase, if an institute is involved with a future roadmap then it will help in making medicine.